Current Report Filing (8-k)
February 11 2021 - 4:36PM
Edgar (US Regulatory)
United
States
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 8, 2021
Cemtrex
Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-37464
|
|
30-0399914
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
276
Greenpoint Ave Bld. 8 Suite 208
Brooklyn,
NY
|
|
11101
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (631) 756-9116
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
symbol
|
|
Name
of each exchange on which registered
|
Common
Stock
|
|
CETX
|
|
Nasdaq
Capital Market
|
Series
1 Preferred Stock
|
|
CETXP
|
|
Nasdaq
Capital Market
|
Series
1 Warrants
|
|
CETXW
|
|
Nasdaq
Capital Market
|
CURRENT
REPORT ON FORM 8-K
Cemtrex,
Inc.
February
10, 2021
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On
February 8, 2021, Cemtrex, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department
of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because of the resignation of Raju Panjwani
from the Company’s board and audit committee, effective January 25, 2021, the Company no longer complies with Nasdaq’s
audit committee requirements as set forth in Listing Rule 5605.
The
notification letter also disclosed that Nasdaq will provide the Company a cure period in order to regain compliance as follows:
|
●
|
until
the earlier of the Company’s next annual shareholders’ meeting or January
25, 2022; or
|
|
|
|
|
●
|
if
the next annual shareholders’ meeting is held before July 26, 2021, then the Company
must evidence compliance no later than July 26, 2021.
|
The
Company intends to have a replacement for Mr. Panjwani’s seat on the board and the audit committee prior to the expiration
of the cure period.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CEMTREX,
INC.
|
|
|
Date:
February 11, 2021
|
By:
|
/s/
Saagar Govil
|
|
|
Saagar
Govil
|
|
|
Chairman,
President and Chief Executive Officer
|
Cemtrex (NASDAQ:CETX)
Historical Stock Chart
From Apr 2024 to May 2024
Cemtrex (NASDAQ:CETX)
Historical Stock Chart
From May 2023 to May 2024